Allurion Technologies Inc. (NYSE:ALUR) Short Interest Update

Allurion Technologies Inc. (NYSE:ALUR) was the target of a large decrease in short interest in January. As of January 15th, there was short interest totalling 46,700 shares, a decrease of 95.6% from the December 31st total of 1,060,000 shares. Approximately 2.4% of the shares of the stock are short sold. Based on an average daily volume of 27,600 shares, the short-interest ratio is currently 1.7 days.

Institutional Trading of Allurion Technologies

An institutional investor recently raised its position in Allurion Technologies stock. Geode Capital Management LLC grew its holdings in Allurion Technologies Inc. (NYSE:ALUR) by 40.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 516,330 shares of the company’s stock after purchasing an additional 149,484 shares during the period. Geode Capital Management LLC owned about 0.80% of Allurion Technologies worth $317,000 as of its most recent SEC filing. 21.39% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. TD Cowen assumed coverage on Allurion Technologies in a research note on Wednesday, October 2nd. They issued a “buy” rating and a $50.00 target price on the stock. Chardan Capital lowered Allurion Technologies from a “buy” rating to a “neutral” rating in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $71.88.

Allurion Technologies Trading Down 20.6 %

NYSE:ALUR traded down $1.41 during trading hours on Tuesday, reaching $5.44. 790,952 shares of the company traded hands, compared to its average volume of 4,723,512. The business’s 50-day moving average price is $8.07 and its two-hundred day moving average price is $14.33. The stock has a market capitalization of $14.08 million, a P/E ratio of -0.45 and a beta of -0.62. Allurion Technologies has a 1 year low of $2.37 and a 1 year high of $98.75.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.